Pitta Guilherme Benjamin Brandão, Pereira Deise Azevedo, Oliveira Milena de Fátima Queiroz, Guedes Eduardo Abadie, Sampaio Joaquim Araújo
Universidade Estadual de Ciências da Saúde de Alagoas - UNCISAL, Faculdade de Medicina, Maceió, AL, Brasil.
Universidade Federal de Alagoas - UFAL, Faculdade de Medicina, Maceió, AL, Brasil.
J Vasc Bras. 2017 Jan-Mar;16(1):43-47. doi: 10.1590/1677-5449.008416.
Portal vein thrombosis is a rare vascular cause of acute abdomen and it is directly related to hereditary or acquired thrombophilias. This article presents the case of a 60-year-old male patient, with clinical signs of mesenteric ischemia that was confirmed by imaging examination. He underwent enterectomy and enteroanastomosis and, after detection of portal vein thrombosis by splenoportography, he was prescribed drug-based treatment with continuous infusion of recombinant tissue plasminogen activator (Alteplase) via selective catheterization of the superior mesenteric artery. This is a treatment innovation. The portal system was successfully recanalized. However, the patient developed abdominal sepsis and required intensive care for 25 days. His clinical status improved and he was discharged with a prescription for oral anticoagulant. This article presents a brief review of the literature and a discussion of portal vein thrombosis.
门静脉血栓形成是急性腹痛一种罕见的血管病因，它与遗传性或获得性血栓形成倾向直接相关。本文介绍了一名60岁男性患者的病例，其具有肠系膜缺血的临床体征，经影像学检查得以证实。他接受了肠切除术和肠吻合术，在通过脾门静脉造影检测到门静脉血栓形成后，通过选择性肠系膜上动脉导管插入术持续输注重组组织型纤溶酶原激活剂（阿替普酶）对其进行了药物治疗。这是一种治疗创新。门静脉系统成功再通。然而，患者发生了腹部脓毒症，需要重症监护25天。他的临床状况有所改善，出院时开具了口服抗凝剂处方。本文对文献进行了简要综述并讨论了门静脉血栓形成。
